IDEXX Laboratories (IDXX) Rebounds On Jefferies Support, Is It Still 20% Undervalued?

IDEXX Laboratories (IDXX) drew fresh attention after Jefferies reiterated its Buy rating while cutting two animal health peers on pricing concerns, and highlighted diagnostics as relatively better insulated within the broader veterinary and livestock market. Recent trading has shifted in IDEXX Laboratories' favor, with a 7 day share price return of 5.47% and a 30 day share price gain of 8.27%. However, the year to date share price return is down 16.73% and the 1 year total shareholder return...